Irfan Mohammed

US Patent:

20200352928, Nov 12, 2020

Filed:

Jul 20, 2020

Appl. No.:

16/933642

Inventors:

- Bridgewater NJ, US
Prem Sagar Akasapu - Edison NJ, US
Irfan A. Mohammed - Cherry Hill NJ, US
Kumaresh Soppimath - Skillman NJ, US
Iouri V. Ilitchev - Hillsborough NJ, US

International Classification:

A61K 31/46
A61K 9/00
A61K 47/38
A61K 47/02
A61K 47/18
A61K 9/08

Abstract:

The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.

US Patent:

20190209545, Jul 11, 2019

Filed:

Feb 20, 2019

Appl. No.:

16/280384

Inventors:

- Bridgewater NJ, US
Prem Sagar Akasapu - Edison NJ, US
Irfan A. Mohammed - Cherry Hill NJ, US
Kumaresh Soppimath - Skillman NJ, US
Iouri V. Ilitchev - Hillsborough NJ, US

International Classification:

A61K 31/46
A61K 9/08
A61K 47/18
A61K 9/00
A61K 47/38
A61K 47/02

Abstract:

The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.

US Patent:

20190192499, Jun 27, 2019

Filed:

Feb 20, 2019

Appl. No.:

16/280552

Inventors:

- Bridgewater NJ, US
Prem Sagar Akasapu - Edison NJ, US
Irfan A. Mohammed - Cherry Hill NJ, US
Kumaresh Soppimath - Skillman NJ, US
Iouri V. Ilitchev - Hillsborough NJ, US

International Classification:

A61K 31/46
A61K 9/08
A61K 47/18
A61K 9/00
A61K 47/38
A61K 47/02

Abstract:

The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.

US Patent:

20190183876, Jun 20, 2019

Filed:

Feb 20, 2019

Appl. No.:

16/280669

Inventors:

- Bridgewater NJ, US
Prem Sagar Akasapu - Edison NJ, US
Irfan A. Mohammed - Cherry Hill NJ, US
Kumaresh Soppimath - Skillman NJ, US
Iouri V. Ilitchev - Hillsborough NJ, US

International Classification:

A61K 31/46
A61K 9/08
A61K 47/18
A61K 9/00
A61K 47/38
A61K 47/02

Abstract:

The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.

US Patent:

20190175579, Jun 13, 2019

Filed:

Feb 20, 2019

Appl. No.:

16/280405

Inventors:

- Bridgewater NJ, US
Prem Sagar Akasapu - Edison NJ, US
Irfan A. Mohammed - Cherry Hill NJ, US
Kumaresh Soppimath - Skillman NJ, US
Iouri V. Ilitchev - Hillsborough NJ, US

International Classification:

A61K 31/46
A61K 9/08
A61K 47/18
A61K 9/00
A61K 47/38
A61K 47/02

Abstract:

The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.

US Patent:

20190175580, Jun 13, 2019

Filed:

Feb 20, 2019

Appl. No.:

16/280585

Inventors:

- Bridgewater NJ, US
Prem Sagar Akasapu - Edison NJ, US
Irfan A. Mohammed - Cherry Hill NJ, US
Kumaresh Soppimath - Skillman NJ, US
Iouri V. Ilitchev - Hillsborough NJ, US

International Classification:

A61K 31/46
A61K 9/08
A61K 47/18
A61K 9/00
A61K 47/38
A61K 47/02

Abstract:

The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.

US Patent:

20180325888, Nov 15, 2018

Filed:

May 10, 2018

Appl. No.:

15/976279

Inventors:

- Bridgewater NJ, US
Prem Sagar Akasapu - Edison NJ, US
Irfan A. Mohammed - Cherry Hill NJ, US
Kumaresh Soppimath - Skillman NJ, US
Iouri V. Ilitchev - Hillsborough NJ, US
Tao Zhang - Towaco NJ, US

International Classification:

A61K 31/46
A61K 9/00
A61K 9/08
A61K 47/02
A61K 47/18
A61K 47/38

Abstract:

The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.